Effect of Lollipop on Emergence Delirium in Pediatric Patients Undergoing General Anesthesia
Effect of Lollipop on Emergence Delirium in Pediatric Patients Undergoing General Anesthesia: A Randomized Controlled Trial
Udayana University
66 participants
Apr 10, 2026
INTERVENTIONAL
Conditions
Summary
This study aims to evaluate the effectiveness of lollipop administration after surgery in reducing emergence agitation in pediatric patients undergoing anesthesia with sevoflurane at RS Ngoerah. Emergence agitation is a common condition in children after general anesthesia, characterized by restlessness, confusion, and distress during recovery. This study investigates whether providing a lollipop as a simple, non-pharmacological intervention can help reduce the incidence and severity of agitation. Pediatric patients undergoing surgery with sevoflurane anesthesia will be observed postoperatively, and their level of agitation will be assessed using standardized evaluation methods. The results of this study are expected to provide a safe, practical, and easily applicable approach to improve postoperative recovery in children.
Eligibility
Inclusion Criteria4
- Pediatric patients aged 2-6 years
- Scheduled for elective surgery under general anesthesia with sevoflurane
- American Society of Anesthesiologists (ASA) physical status I-II
- Written informed consent obtained from parents or legal guardians
Exclusion Criteria5
- Known allergy or contraindication to study-related procedures
- Developmental delay or neurological disorders affecting behavior assessment
- Use of sedative or psychoactive medications prior to surgery
- History of emergence delirium or significant behavioral disorders
- Intraoperative complications requiring deviation from standard anesthesia protocol
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
This study is a prospective, parallel-group, randomized controlled trial. Pediatric patients undergoing surgery under sevoflurane anesthesia will be randomly allocated in a 1:1 ratio to either the intervention group (lollipop administration during the immediate postoperative period) or the control group (standard care). Randomization will be performed using a computer-generated sequence, with allocation concealment as appropriate. Outcome assessors will evaluate emergence agitation using standardized scales. The primary endpoint is the incidence and severity of emergence agitation. Secondary endpoints include recovery time and postoperative comfort.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07571707